Cargando…

The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases

OBJECTIVE: To understand the varieties, evaluation, treatment, and prognosis of severe neurological diseases using the third NCU survey in China. DESIGN: A cross-sectional questionnaire study. The study was completed in three main steps: filling in the questionnaire, sorting out the survey data, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yingying, Teng, Junfang, Tian, Fei, Jing, Jing, Huang, Huijin, Pan, Suyue, Jiang, Wen, Wang, Furong, Zhang, Le, Zhang, Yan, Zhang, Meng, Liu, Liping, Cao, Jie, Hu, Huaiqiang, Li, Wei, Liang, Cheng, Ma, Liansheng, Meng, Xuegang, Tian, Linyu, Wang, Changqing, Wang, Lihua, Wang, Yan, Wang, Zhenhai, Wang, Zhiqiang, Xie, Zunchun, You, Mingyao, Yuan, Jun, Zeng, Chaosheng, Zeng, Li, Zhang, Lei, Zhang, Xin, Zhang, Yongwei, Zhao, Bin, Zhou, Saijun, Zhou, Zhonghe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990414/
https://www.ncbi.nlm.nih.gov/pubmed/36895910
http://dx.doi.org/10.3389/fneur.2023.1114204
_version_ 1784901936072359936
author Su, Yingying
Teng, Junfang
Tian, Fei
Jing, Jing
Huang, Huijin
Pan, Suyue
Jiang, Wen
Wang, Furong
Zhang, Le
Zhang, Yan
Zhang, Meng
Liu, Liping
Cao, Jie
Hu, Huaiqiang
Li, Wei
Liang, Cheng
Ma, Liansheng
Meng, Xuegang
Tian, Linyu
Wang, Changqing
Wang, Lihua
Wang, Yan
Wang, Zhenhai
Wang, Zhiqiang
Xie, Zunchun
You, Mingyao
Yuan, Jun
Zeng, Chaosheng
Zeng, Li
Zhang, Lei
Zhang, Xin
Zhang, Yongwei
Zhao, Bin
Zhou, Saijun
Zhou, Zhonghe
author_facet Su, Yingying
Teng, Junfang
Tian, Fei
Jing, Jing
Huang, Huijin
Pan, Suyue
Jiang, Wen
Wang, Furong
Zhang, Le
Zhang, Yan
Zhang, Meng
Liu, Liping
Cao, Jie
Hu, Huaiqiang
Li, Wei
Liang, Cheng
Ma, Liansheng
Meng, Xuegang
Tian, Linyu
Wang, Changqing
Wang, Lihua
Wang, Yan
Wang, Zhenhai
Wang, Zhiqiang
Xie, Zunchun
You, Mingyao
Yuan, Jun
Zeng, Chaosheng
Zeng, Li
Zhang, Lei
Zhang, Xin
Zhang, Yongwei
Zhao, Bin
Zhou, Saijun
Zhou, Zhonghe
author_sort Su, Yingying
collection PubMed
description OBJECTIVE: To understand the varieties, evaluation, treatment, and prognosis of severe neurological diseases using the third NCU survey in China. DESIGN: A cross-sectional questionnaire study. The study was completed in three main steps: filling in the questionnaire, sorting out the survey data, and analyzing the survey data. RESULTS: Of 206 NCUs, 165 (80%) provided relatively complete information. It was estimated that 96,201 patients with severe neurological diseases were diagnosed and treated throughout the year, with an average fatality rate of 4.1%. The most prevalent severe neurological disease was cerebrovascular disease (55.2%). The most prevalent comorbidity was hypertension (56.7%). The most prevalent complication was hypoproteinemia (24.2%). The most common nosocomial infection was hospital-acquired pneumonia (10.6%). The GCS, APACHE II, EEG, and TCD were the most commonly used (62.4–95.2%). The implementation rate of the five nursing evaluation techniques reached 55.8–90.9%. Routinely raising the head of the bed by 30°, endotracheal intubation and central venous catheterization were the mostprevalent treatment strategies (97.6, 94.5, and 90.3%, respectively). Traditional tracheotomy, invasive mechanical ventilation and nasogastric tube feeding (75.8, 95.8, and 95.8%, respectively) were more common than percutaneous tracheotomy, non-invasive mechanical ventilation and nasogastric tube insertion (57.6, 57.6, and 66.7%, respectively). Body surface hypothermia brain protection technology was more commonly used than intravascular hypothermia technology (67.3 > 6.1%). The rates of minimally invasive hematoma removal and ventricular puncture were only 40.0 and 45.5%, respectively. CONCLUSION: In addition to traditional recognized basic life assessment and support technology, it is necessary to the use of promote specialized technology for neurological diseases, according to the characteristics of critical neurological diseases.
format Online
Article
Text
id pubmed-9990414
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99904142023-03-08 The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases Su, Yingying Teng, Junfang Tian, Fei Jing, Jing Huang, Huijin Pan, Suyue Jiang, Wen Wang, Furong Zhang, Le Zhang, Yan Zhang, Meng Liu, Liping Cao, Jie Hu, Huaiqiang Li, Wei Liang, Cheng Ma, Liansheng Meng, Xuegang Tian, Linyu Wang, Changqing Wang, Lihua Wang, Yan Wang, Zhenhai Wang, Zhiqiang Xie, Zunchun You, Mingyao Yuan, Jun Zeng, Chaosheng Zeng, Li Zhang, Lei Zhang, Xin Zhang, Yongwei Zhao, Bin Zhou, Saijun Zhou, Zhonghe Front Neurol Neurology OBJECTIVE: To understand the varieties, evaluation, treatment, and prognosis of severe neurological diseases using the third NCU survey in China. DESIGN: A cross-sectional questionnaire study. The study was completed in three main steps: filling in the questionnaire, sorting out the survey data, and analyzing the survey data. RESULTS: Of 206 NCUs, 165 (80%) provided relatively complete information. It was estimated that 96,201 patients with severe neurological diseases were diagnosed and treated throughout the year, with an average fatality rate of 4.1%. The most prevalent severe neurological disease was cerebrovascular disease (55.2%). The most prevalent comorbidity was hypertension (56.7%). The most prevalent complication was hypoproteinemia (24.2%). The most common nosocomial infection was hospital-acquired pneumonia (10.6%). The GCS, APACHE II, EEG, and TCD were the most commonly used (62.4–95.2%). The implementation rate of the five nursing evaluation techniques reached 55.8–90.9%. Routinely raising the head of the bed by 30°, endotracheal intubation and central venous catheterization were the mostprevalent treatment strategies (97.6, 94.5, and 90.3%, respectively). Traditional tracheotomy, invasive mechanical ventilation and nasogastric tube feeding (75.8, 95.8, and 95.8%, respectively) were more common than percutaneous tracheotomy, non-invasive mechanical ventilation and nasogastric tube insertion (57.6, 57.6, and 66.7%, respectively). Body surface hypothermia brain protection technology was more commonly used than intravascular hypothermia technology (67.3 > 6.1%). The rates of minimally invasive hematoma removal and ventricular puncture were only 40.0 and 45.5%, respectively. CONCLUSION: In addition to traditional recognized basic life assessment and support technology, it is necessary to the use of promote specialized technology for neurological diseases, according to the characteristics of critical neurological diseases. Frontiers Media S.A. 2023-02-21 /pmc/articles/PMC9990414/ /pubmed/36895910 http://dx.doi.org/10.3389/fneur.2023.1114204 Text en Copyright © 2023 Su, Teng, Tian, Jing, Huang, Pan, Jiang, Wang, Zhang, Zhang, Zhang, Liu, Cao, Hu, Li, Liang, Ma, Meng, Tian, Wang, Wang, Wang, Wang, Wang, Xie, You, Yuan, Zeng, Zeng, Zhang, Zhang, Zhang, Zhao, Zhou and Zhou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Su, Yingying
Teng, Junfang
Tian, Fei
Jing, Jing
Huang, Huijin
Pan, Suyue
Jiang, Wen
Wang, Furong
Zhang, Le
Zhang, Yan
Zhang, Meng
Liu, Liping
Cao, Jie
Hu, Huaiqiang
Li, Wei
Liang, Cheng
Ma, Liansheng
Meng, Xuegang
Tian, Linyu
Wang, Changqing
Wang, Lihua
Wang, Yan
Wang, Zhenhai
Wang, Zhiqiang
Xie, Zunchun
You, Mingyao
Yuan, Jun
Zeng, Chaosheng
Zeng, Li
Zhang, Lei
Zhang, Xin
Zhang, Yongwei
Zhao, Bin
Zhou, Saijun
Zhou, Zhonghe
The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases
title The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases
title_full The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases
title_fullStr The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases
title_full_unstemmed The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases
title_short The development of neurocritical care in China from the perspective of evaluation and treatment of critical neurological diseases
title_sort development of neurocritical care in china from the perspective of evaluation and treatment of critical neurological diseases
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9990414/
https://www.ncbi.nlm.nih.gov/pubmed/36895910
http://dx.doi.org/10.3389/fneur.2023.1114204
work_keys_str_mv AT suyingying thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT tengjunfang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT tianfei thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT jingjing thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT huanghuijin thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT pansuyue thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT jiangwen thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wangfurong thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhangle thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhangyan thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhangmeng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT liuliping thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT caojie thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT huhuaiqiang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT liwei thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT liangcheng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT maliansheng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT mengxuegang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT tianlinyu thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wangchangqing thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wanglihua thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wangyan thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wangzhenhai thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wangzhiqiang thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT xiezunchun thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT youmingyao thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT yuanjun thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zengchaosheng thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zengli thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhanglei thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhangxin thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhangyongwei thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhaobin thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhousaijun thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhouzhonghe thedevelopmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT suyingying developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT tengjunfang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT tianfei developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT jingjing developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT huanghuijin developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT pansuyue developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT jiangwen developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wangfurong developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhangle developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhangyan developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhangmeng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT liuliping developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT caojie developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT huhuaiqiang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT liwei developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT liangcheng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT maliansheng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT mengxuegang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT tianlinyu developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wangchangqing developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wanglihua developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wangyan developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wangzhenhai developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT wangzhiqiang developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT xiezunchun developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT youmingyao developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT yuanjun developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zengchaosheng developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zengli developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhanglei developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhangxin developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhangyongwei developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhaobin developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhousaijun developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases
AT zhouzhonghe developmentofneurocriticalcareinchinafromtheperspectiveofevaluationandtreatmentofcriticalneurologicaldiseases